8-K
Current Report
Adaptimmune Therapeutics PLC Filed Acc 0001558370-22-010042
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading adap-20220615x8k.htm…